Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iulia M Nita

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Communications Biology|June 29, 2026
Nuclear RNA clusters are dynamic structural entities in Huntington's diseaseSandra Fienko, Iulia M Nita, Ignacio Munoz-Munoz, et al.
Brain Communications|February 19, 2024
Translatable plasma and CSF biomarkers for use in mouse models of Huntington's diseaseMarie K Bondulich, Jemima Phillips, María Cañibano-Pico, et al.
Brain Communications|December 23, 2024
Mutant huntingtin protein decreases with CAG repeat expansion: implications for therapeutics and bioassaysChristian Landles, Georgina F Osborne, Jemima Phillips, et al.
Brain : a Journal of Neurology|February 22, 2024
A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's diseaseSarah G Aldous, Edward J Smith, Christian Landles, et al.
Brain : a Journal of Neurology|February 2, 2026
The HTT1a protein initiates HTT aggregation in a knock-in mouse model of Huntington's diseaseAikaterini Smaragdi Papadopoulou, Christian Landles, Edward J Smith, et al.
Science Translational Medicine|March 18, 2026
Lowering the <i>HTT1a</i> transcript as an effective therapy for Huntington's disease in a knockin mouse modelAikaterini Smaragdi Papadopoulou, Julia Alterman, Christian Landles, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Communications Biology|June 29, 2026
Nuclear RNA clusters are dynamic structural entities in Huntington's diseaseSandra Fienko, Iulia M Nita, Ignacio Munoz-Munoz, et al.
Brain Communications|February 19, 2024
Translatable plasma and CSF biomarkers for use in mouse models of Huntington's diseaseMarie K Bondulich, Jemima Phillips, María Cañibano-Pico, et al.
Brain Communications|December 23, 2024
Mutant huntingtin protein decreases with CAG repeat expansion: implications for therapeutics and bioassaysChristian Landles, Georgina F Osborne, Jemima Phillips, et al.
Brain : a Journal of Neurology|February 22, 2024
A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's diseaseSarah G Aldous, Edward J Smith, Christian Landles, et al.
Brain : a Journal of Neurology|February 2, 2026
The HTT1a protein initiates HTT aggregation in a knock-in mouse model of Huntington's diseaseAikaterini Smaragdi Papadopoulou, Christian Landles, Edward J Smith, et al.
Science Translational Medicine|March 18, 2026
Lowering the <i>HTT1a</i> transcript as an effective therapy for Huntington's disease in a knockin mouse modelAikaterini Smaragdi Papadopoulou, Julia Alterman, Christian Landles, et al.
Pageof 1